Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers

Next Previous
Trial Profile

Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 30 May 2016

At a glance

  • Drugs Nebicapone (Primary) ; Warfarin
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors Bial

    • Most Recent Events

    • 30 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top